Murine Mesenchymal Stem Cells Suppress T Lymphocyte Activation Through IL-2 Receptor α (CD25) Cleavage by Producing Matrix Metalloproteinases

Stem Cell Reviews and Reports

Volumn 7, Issue 2, 2011, Pages 381-393

  Park, Min Jung ^a,b   Shin, Jun Seop ^a,b   Kim, Yong Hee ^a,b   Hong, So Hee ^a,b   Yang, Seung Ha ^a,b   Shin, Jin Young ^a,b   Kim, Su Young ^a,b   Kim, Bongi ^a,b   Kim, Jung Sik ^a,b   Park, Chung Gyu ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Apoptosis; CD25 cleavage; Cell cycle arrest; Matrix metalloproteinases; Mouse mesenchymal stem cells; T cell suppression

Indexed keywords

CCND2 PROTEIN, MOUSE; CDK2 PROTEIN, MOUSE; CDKN1B PROTEIN, MOUSE; CYCLIN D2; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DIPEPTIDE; IL2RA PROTEIN, MOUSE; ILOMASTAT; INTERLEUKIN 2 RECEPTOR ALPHA; MATRIX METALLOPROTEINASE; PROTEIN BCL 2; STAT5 PROTEIN;

ANIMAL; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; C57BL MOUSE; CELL CULTURE; CELL PROLIFERATION; CULTURE MEDIUM; DRUG ANTAGONISM; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE ACTIVATION; MESENCHYMAL STEM CELL; METABOLISM; MOUSE; SECRETION; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYCLIN D2; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DIPEPTIDES; IMMUNOSUPPRESSION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MATRIX METALLOPROTEINASES; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PROTO-ONCOGENE PROTEINS C-BCL-2; STAT5 TRANSCRIPTION FACTOR; T-LYMPHOCYTES;

MURINAE;

EID: 79955047654     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-010-9203-9     Document Type: Article

References (27)

1. Rasmusson, I. (2006). Immune modulation by mesenchymal stem cells. Experimental Cell Research, 312, 2169-2179.
2. Yang, S. H., Park, M. J., Yoon, I. H., et al. (2009). Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10. Experimental and Molecular Medicine, 41, 315-324.
3. Kasper, G., Dankert, N., Tuischer, J., et al. (2007). Mesenchymal stem cells regulate angiogenesis according to their mechanical environment. Stem Cells, 25, 903-910.
4. Aggarwal, S., & Pittenger, M. F. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 105, 1815-1822.
5. Zappia, E., Casazza, S., Pedemonte, E., et al. (2005). Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood, 106, 1755-1761.
6. Augello, A., Tasso, R., Negrini, S. M., et al. (2005). Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. European Journal of Immunology, 35, 1482-1490.
7. Sato, K., Ozaki, K., Oh, I., et al. (2007). Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood, 109, 228-234.
8. Di Nicola, M., Carlo-Stella, C., Magni, M., et al. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 99, 3838-3843.
9. Le Blanc, K., Rasmusson, I., Gotherstrom, C., et al. (2004). Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scandinavian Journal of Immunology, 60, 307-315.
10. Glennie, S., Soeiro, I., Dyson, P. J., Lam, E. W., & Dazzi, F. (2005). Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood, 105, 2821-2827.
11. Coats, S., Flanagan, W. M., Nourse, J., & Roberts, J. M. (1996). Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science, 272, 877-880.
12. Ries, C., Egea, V., Karow, M., Kolb, H., Jochum, M., & Neth, P. (2007). MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood, 109, 4055-4063.
13. Mannello, F., Tonti, G. A., Bagnara, G. P., & Papa, S. (2006). Role and function of matrix metalloproteinases in the differentiation and biological characterization of mesenchymal stem cells. Stem Cells, 24, 475-481.
14. Djouad, F., Delorme, B., Maurice, M., et al. (2007). Microenvironmental changes during differentiation of mesenchymal stem cells towards chondrocytes. Arthritis Research & Therapy, 9, R33.
15. O'Shea, J. J., Ma, A., & Lipsky, P. (2002). Cytokines and autoimmunity. Nature Reviews. Immunology, 2, 37-45.
16. Bank, U., Reinhold, D., Schneemilch, C., Kunz, D., Synowitz, H. J., & Ansorge, S. (1999). Selective proteolytic cleavage of IL-2 receptor and IL-6 receptor ligand binding chains by neutrophil-derived serine proteases at foci of inflammation. Journal of Interferon & Cytokine Research, 19, 1277-1287.
17. Schulz, O., Sewell, H. F., & Shakib, F. (1998). Proteolytic cleavage of CD25, the alpha subunit of the human T cell interleukin 2 receptor, by Der p 1, a major mite allergen with cysteine protease activity. The Journal of Experimental Medicine, 187, 271-275.
18. Sheu, B. C., Hsu, S. M., Ho, H. N., Lien, H. C., Huang, S. C., & Lin, R. H. (2001). A novel role of metalloproteinase in cancer-mediated immunosuppression. Cancer Research, 61, 237-242.
19. Levi, E., Fridman, R., Miao, H. Q., Ma, Y. S., Yayon, A., & Vlodavsky, I. (1996). Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. Proceedings of the National Academy of Sciences of the United States of America, 93, 7069-7074.
20. Ding, Y., Xu, D., Feng, G., Bushell, A., Muschel, R. J., & Wood, K. J. (2009). Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9. Diabetes, 58, 1797-1806.
21. Blasi, F., & Carmeliet, P. (2002). uPAR: a versatile signalling orchestrator. Nature Reviews. Molecular Cell Biology, 3, 932-943.
22. Najar, M., Rouas, R., Raicevic, G., et al. (2009). Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6. Cytotherapy, 11, 570-583.
23. Sheng, H., Wang, Y., Jin, Y., et al. (2008). A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1. Cell Research, 18, 846-857.
24. Ren, G., Zhao, X., Zhang, L., et al. (2010). Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. Journal of Immunology, 184, 2321-2328.
25. Wagner, W., Horn, P., Castoldi, M., et al. (2008). Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS ONE, 3, e2213.
26. Thornton, A. M. (2006). Signal transduction in CD4+CD25+ regulatory T cells: CD25 and IL-2. Frontiers in Bioscience, 11, 921-927.
27. Lim, J. H., Kim, J. S., Yoon, I. H., et al. (2010). Immunomodulation of delayed-type hypersensitivity responses by mesenchymal stem cells is associated with bystander T cell apoptosis in the draining lymph node. Journal of Immunology, 185, 4022-4029.